Medical Policy Update
Blue Cross and Blue Shield of Kansas (BCBSKS) has published the following updated medical policies on our website on February 1, 2024.
Effective 03/01/24:
- Hemophilia A Gene Therapy Medical Drug Criteria Program Summary
To view these medical policies, please visit our Medical Policy page of our website, https://www.bcbsks.com/providers/medical-policies.
Pharmacy Medical Policy Update
The following Pharmacy Medical Policy programs have been updated February 1, 2024:
Effective 03/01/24:
- Biologic Immunomodulators
- IL-1 Inhibitors
- Cibinqo
- IL-4 Inhibitor
- IL-5 Inhibitors
- Tezspire
- Xolair
- Lupus
- Opzelura
- Weight Loss Agents
- Statin
Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.
To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.
If you have questions regarding this publication, please contact your BCBSKS provider consultant/representative.